Pay in 4 interest-free payments of $5.18 Learn more
Ships within 48 hours · Estimated delivery Aug 15 - Aug 20
$150 OFF First Order New Patients $149 $349 On average patients lose 9.6 pounds in their first 30 days
Substance Powder-based semaglutide Development phase Preclinical Temperature stability 1 0.1% degradation after 6 months 2 Administration Nasal powder (other delivery routes are explored) Leverage established manufacturing processes Spray-drying process (intranasal delivery) Partnership Seeking partnership for continued research and development Demonstrating strong preclinical performance A preclinical in-vivo study evaluated three powder-based intranasal semaglutide formulations developed with AmorphOX
The sampling time was shown in Table 1
BPC-157 Laboratory Research BPC-157 is a synthetic pentadecapeptide that has been investigated in laboratory research involving peptide biology, receptor interactions, molecular signaling pathways, protein expression, cellular communication, and experimental pharmacology
Start your intake Understanding Noom's Behavioral-First Model Noom operates as a digital wellness platform combining cognitive behavioral therapy principles with daily food logging, habit tracking, and personal coaching
US$ 24.07
US$ 25.51
US$ 20.35
